CSS® Encapsulation Equipment
EncapSure™Precision-Made for Advanced Drug Delivery – Available H1 2026
Likarda’s proprietary Core Shell Spherification® (CSS®) technology is now being engineered for in-house use—empowering pharmaceutical, biotech, and cell therapy teams to encapsulate their own products with precision and scalability.
Launching in H1 2026, our closed CSS® instrument, EncapSure™, brings together automated microbead generation, modular fluid control, and combined rinse and crosslinking workflows and integrated QC to deliver a fully enclosed, GMP-ready solution for preclinical, clinical and commercial use.
Why EncapSure™?
Standardized & Scalable
From early-stage R&D to commercial manufacturing, the CSS® system adapts to your throughput needs.
Automated Workflow
Reduce manual variability with enclosed fluidics, programmable batch parameters, and rinse automation.
Compatible Inputs
Designed for cells, biologics, peptides, and small molecules in aqueous or lightly viscous solutions.
Versatile Output
Supports live encapsulated products for just-in-time delivery and cryopreserved formats for long-term storage.
Rapid Setup
Ready to run in under 60 minutes with encapsulation runs completed in as little as 30 minutes
Key Use Cases
- In-house preclinical testing of therapeutics
- GMP manufacturing of injectable cell therapies
- Extended-release formulations for biologics and peptides
- Encapsulation of cryopreserved or fresh cells for global logistics
Let’s Get You Ready for 2026
Contact us to learn more about equipment availability, installation timelines, and early adopter pricing.